Sodium Bicarbonate Syringe Availability Announced in Response to Shortage

Sodium Bicarbonate is indicated to treat metabolic acidosis, certain drug intoxications, and in severe diarrhea
Sodium Bicarbonate is indicated to treat metabolic acidosis, certain drug intoxications, and in severe diarrhea

QuVa Pharma announced the availability of Sodium Bicarbonate PF 8.4% (1mEq/mL), 50mEq per syringe, in response to the nationwide shortage of pharmaceutical quality sodium bicarbonate for hospitals. The product is sourced from a United States FDA-approved manufacturer and is accompanied by a Certificate of Analysis and product specifications. 

Sodium Bicarbonate is indicated to treat metabolic acidosis, certain drug intoxications, and in severe diarrhea. It works by increasing plasma bicarbonate, buffering excess hydrogen ion concentration, raising blood pH, and reversing the clinical manifestations of acidosis. 

Related Articles

QuVa will be supplying Sodium Bicarbonate PF 8.4% to both current and new customers. 

For more information call (888) 339-0874 or visit QuVapharma.com.